간편하게 보는 뉴스는 유니콘뉴스
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform

· 등록일 Aug. 16, 2024 15:40

· 업데이트일 2024-08-17 00:02:18

MINNEAPOLIS--(Business Wire / Korea Newswire)--HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today the completion of an oversubscribed $102 million Series D financing. The round was led by Alpha Wave Ventures, a world leader in growth stage investments, with participation from new investors Amzak Health and HealthQuest Capital, and existing investors Johnson & Johnson Innovation - JJDC, Inc. (JJDC), Venture Investors, Lumira Ventures, Yonjin Venture, the State of Wisconsin Investment Board, and others.

HistoSonics Edison® Histotripsy System (Photo: Business Wire) HistoSonics Edison® Histotripsy System (Photo: Business Wire) Histotripsy is a novel form of focused ultrasound that uses high amplitude, very short pulses to create a “bubble cloud” that is designed to mechanically destroy and liquefy targeted liver tumors. These bubble clouds form and collapse in microseconds, creating mechanical forces strong enough to destroy tissue at cellular and sub-cellular levels in a non-invasive and non-thermal method. Histotripsy offers a promising alternative to treatments such as surgery, radiation and chemotherapy, which often have significant side effects.

The Series D funding will be used to accelerate category defining advancements to its non-invasive histotripsy platforms, support commercial growth in the US and in planned global markets, and initiate the company’s innovative, prospective BOOMBOX Master Study that will evaluate HistoSonics’ Edison System for the treatment of liver tumors across multidisciplinary users. The Edison Histotripsy System was granted FDA De Novo clearance in October 2023. HistoSonics is currently partnering with leading institutions across the US and internationally in developing multi-disciplinary histotripsy liver programs.

“Histotripsy is a paradigm-changing treatment option for patients who want a non-invasive approach to target and destroy tumors without the need for needles or incisions,” said Mike Blue, President & CEO, HistoSonics. “We’re thrilled to announce this top-tier investor syndicate led by Alpha Wave, which reinforces the confidence in our mission to impact patients’ lives with our current liver application and expanded use in kidney, pancreas, prostate, brain and other tumor types. This funding will accelerate key projects designed to enhance core technical capabilities impacting current and future platforms, and support collaboration with physicians and researchers studying innovative ways to use histotripsy’s unique mechanism of action to improve patient outcomes. By pioneering a new category of medicine with histotripsy, HistoSonics is redefining liver tumor treatment and providing hope for millions of people worldwide who desperately need new options.”

“Alpha Wave is proud to lead the investment in HistoSonics, a pioneer in the use of histotripsy,” said Chris Dimitropoulos, Managing Director, Healthcare Investments at Alpha Wave Global. “Histotripsy’s unique non-invasive approach uses focused ultrasound to precisely target and destroy diseased tissue without damaging surrounding healthy tissue. This groundbreaking technology has the potential to transform the treatment landscape for a variety of challenging clinical conditions, offering patients improved outcomes and recovery times. The level of adoption we’ve seen from leading hospital centers across the country and overseas highlights the huge unmet medical need. We are excited to support HistoSonics in accelerating the development and availability of this innovative therapy.” In connection with this financing, Mr. Dimitropoulos will join the HistoSonics Board of Directors.

HistoSonics' Edison System uses proprietary technology and advanced imaging to deliver personalized, non-invasive histotripsy treatments with precision and control. The novel mechanism of action of this proprietary technology may provide significant patient advantages, including the ability of the treatment site to recover and resorb quickly. HistoSonics’ platform also provides physicians the ability to monitor the destruction of tissue under continuous real-time visualization and control, unlike any modality that exists today.

About HistoSonics

HistoSonics is a privately held medical device company developing non-invasive platforms and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, brain, and others. HistoSonics has offices in Ann Arbor, Michigan, and Minneapolis, Minnesota. The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any specific disease or condition. Patients seeking information on histotripsy and if they may be a candidate for histotripsy can learn more at www.myhistotripsy.com .

Use of the Edison System in kidney applications is limited by federal law to investigational use. The #HOPE4KIDNEY Trial is designed to support a future expansion of the indication to include the destruction of kidney tissue/tumors.

About Alpha Wave

Alpha Wave is a global investment company with three main verticals: private equity, private credit, and public markets. It is led by Rick Gerson, Navroz Udwadia, and Ryan Khoury. Its flagship global private equity fund, Alpha Wave Ventures, aims to invest in best-in-class growth-stage companies and endeavors to be helpful long-term partners to the founders and management teams.

Alpha Wave has offices in Miami, New York, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, and Sydney. For more information, please visit www.alphawaveglobal.com .

For more information please visit: www.histosonics.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20240815865405/en/

Website: https://histosonics.com/ Contact HistoSonics
Media contacts
Vice President of Global Market Access
Josh King
1 608.332.8124
[email protected]

KKH Advisors
Kimberly Ha
917-291-5744
[email protected]
This news is a press release provided by HistoSonics. Korea Newswire follows these editorial guidelines. HistoSonics News ReleasesSubscribeRSS 히스토소닉스, 비침습적 히스토트립시 플랫폼 개시 확장을 위한 1억200만달러 시리즈 D 파이낸싱 초과청약 발표 에디슨 히스토트립시 시스템(Edison® Histotripsy System) 및 새로운 히스토트립시 치료 플랫폼 제조업체인 히스토소닉스 (HistoSonics)가 1억200만달러 규모의 시리즈 D 파이낸싱이 초과 청약되었다고 오늘 발표했다. 이번 라운드는 성장 단계 투자 분야의 세계적인 리더인 알파웨이브 벤처스(Alpha Wave Ven... 8월 16일 15:40 HistoSonics Awarded Key Position in UK’s Novel Innovation Program HistoSonics®, , the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today that the company’s Edison System has been selected to participate in the UK’s newly created Innovative Devices Access Pathway (IDAP) Pilot Program designed to accelerate the d... 2월 15일 10:30 ... More  More News Health Medical Appliances Investment Overseas HistoSonics All News Releases 
배포 분야
인기 기사12.23 12시 기준
광주--(뉴스와이어)--광주청소년삶디자인센터(이하 삶디센터)와 광주전남귀농운동부(이하 귀농운동본부)의 주최로 11월 18일 오후 2시 삶디센터에서 토종벼 탈곡을 체험하고 토종 작물도 살 수 있는 도시농부장터 ‘보자기장’이 열린다. 보자기장에 참여한 시민들이 탈곡...
수원--(뉴스와이어)--경기도장애인복지종합지원센터(이하 누림센터)는 12월 11일 누림센터 대회의실에서 ‘2023년 경기도 장애인을 위한 서비스 프로그램 대상’ 시상식을 성황리에 개최했다. ‘2023년 경기도 장애인을 위한 서비스 프로그램 대상’ 수상자들이 기념사진을...
서울--(뉴스와이어)--세계적인 반려동물 식품 전문기업 네슬레 퓨리나가 기존 제품에서 합성 보존제와 인공색소를 배제한 프리미엄 습식 캣푸드 라인 ‘팬시피스트 화이트라벨’ 리뉴얼 제품을 공개했다. 네슬레 퓨리나, 팬시피스트 화이트라벨...
파주--(뉴스와이어)--변화하는 교육 트렌드에 발맞춰 유아 교육과 생활 전반에서 코딩 및 유아 사고력에 대한 요구가 높아진 가운데 영유아 전문 교육 프로그램 판매사인 킨더네트워크(대표이사 오현권)가 유아를 대상으로 하는 유아 과학 프로그램 ‘놀이언스’를 출시했다. ‘놀이언스’는 유아가 호기심,...
NEW YORK--(Business Wire / Korea Newswire)--There’s room for everyone on ESB’s nice list! The Empire State Building (ESB) announced plans to treat every day like the holidays as it celebrates the 20th anniversary of...
서울--(뉴스와이어)--인터넷신문 제작 전문 다다미디어는 인터넷신문 창간 및 등록, 인터넷신문 운영 전반에 대한 실무 특강을 진행한다고 28일 밝혔다. 인터넷신문 제작 전문 다다미디어는 오는 4월 5일(금)과 4월...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.